J&J offers to buy out Japanese cosmetics firm

Johnson & Johnson signConsumer goods giant Johnson & Johnson (J&J) has announced that it will buy all outstanding shares of Japanese cosmetics and skincare company Ci:z Holdings that it does not already own for approximately 230 billion yen (US$2.05 billion).

Ci:z Holdings handles the marketing, development and distribution of a range of dermocosmetic, cosmetic and skincare products. As part of the deal, J&J will acquire the company’s range of brands including Dr.Ci:Labo, Labo Labo and the Genomer line of skincare products.

J&J hopes the addition of the skincare portfolio will strengthen its market presence in Japan with key customers and expand its offering of science-based dermocosmetic brands.

“Health and beauty consumers are actively seeking science-based innovation to improve their skin,” said Jorge Mesquita, Worldwide Chairman, Johnson & Johnson Consumer.

“This transaction will maximise value creation for Johnson & Johnson’s Consumer business by bringing in an agile innovation model and rapidly accelerating sales through our global commercialization expertise.”

J&J is the second-largest shareholder in the company, owning 19.9 per cent through an affiliate since 2016, allowing it to distribute the brands outside of Japan. J&J will pay 5,900 yen per remaining Ci:z share and will also acquire the shares owned by the Japanese firm’s founder Yoshinori Shirono.

In a statement the company said the deal will provide a strong platform for growing its global innovation pipeline.


Comment Manually

I have read and agree to the Terms and Conditions and Privacy Policy.

FMCG Products



View details

Latest Poll

Is it too early to introduce the Christmas range in supermarkets?

FREE NEWS BRIEFS Get breaking news delivered